Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2025

TCT 46: Transcatheter Delivery of World’s Smallest Leadless Pacemakers for Cardiac Resynchronization Therapy

Presenter: Charles Stark

October 27, 2025

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Conference News TCT 2019

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Todd Neale

October 09, 2019

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Saibal Kar

September 13, 2014

Presentation TCT 2013

Cardiac Resynchronization Therapy in Narrow QRS Patients: The EchoCRT Trial

Presenter: Jagmeet Singh

October 28, 2013

News Conference News

C-Pulse Heart Assist Device Improved Ventricular Remodeling, HF Symptoms

November 07, 2011

Advertisement

TCT 46: Transcatheter Delivery of World’s Smallest Leadless Pacemakers for Cardiac Resynchronization Therapy

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Cardiac Resynchronization Therapy in Narrow QRS Patients: The EchoCRT Trial

C-Pulse Heart Assist Device Improved Ventricular Remodeling, HF Symptoms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content